Related Experiment Video
Updated: Jun 26, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized
Elena von Schlieffen1, Olga V Oskolkova, Gernot Schabbauer
1Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria.
Objective:
Oxidized phospholipids (OxPLs) that are abundant in atherosclerotic lesions are increasingly recognized as context-dependent lipid mediators demonstrating both pro- and antiinflammatory activities. Molecular mechanisms of their effects are largely unknown. Here we present novel information on the mechanisms whereby OxPLs modulate activation of TLR4 by lipopolysaccharide (LPS).
Methods And Results:
We show, using several cell types and various inflammatory genes as readouts, that different classes and molecular species of OxPLs do not stimulate TLR4 but exert prominent inhibitory effects on LPS-induced reactions. Our data demonstrate that binding of OxPLs to the LPS-binding protein (LBP) and CD14 prevents recognition of LPS by these proteins, thus impairing activation of TLR4. In addition, OxPLs inhibited LBP- and CD14-independent activation of TLR4 by the synthetic TLR4 agonist E6020 indicating that in parallel with LBP and CD14, OxPLs target cell-associated steps in TLR4 cascade.
Conclusions:
Our data suggest that OxPLs inhibit action of LPS via a multi-hit mechanism. These results support the notion that OxPLs are endogenous inhibitors of TLR4 produced in response to oxidative stress.
Insights
Oxidized phospholipids (OxPLs) inhibit toll-like receptor 4 (TLR4) activation by lipopolysaccharide (LPS). These findings reveal OxPLs as endogenous inhibitors of TLR4, acting through multiple mechanisms.
Area of Science:
- Immunology
- Lipidomics
- Molecular Biology
Background:
- Oxidized phospholipids (OxPLs) are key lipid mediators in atherosclerosis.
- OxPLs exhibit context-dependent pro- and anti-inflammatory activities.
- Mechanisms underlying OxPLs' effects on inflammation are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which OxPLs modulate toll-like receptor 4 (TLR4) activation by lipopolysaccharide (LPS).
Main Methods:
- Utilized multiple cell types and inflammatory gene expression analysis.
- Investigated OxPLs' effects on LPS-induced TLR4 activation.
- Assessed OxPLs' impact on LPS-binding protein (LBP) and CD14 interactions.
- Examined OxPLs' effects on synthetic TLR4 agonist E6020-induced activation.
Main Results:
- OxPLs do not stimulate TLR4 but inhibit LPS-induced inflammatory responses.
- OxPLs bind to LBP and CD14, preventing LPS recognition and subsequent TLR4 activation.
- OxPLs also inhibit LBP- and CD14-independent TLR4 activation, targeting cell-associated steps.
Conclusions:
- OxPLs inhibit LPS action through a multi-hit mechanism.
- OxPLs act as endogenous inhibitors of TLR4.
- These inhibitory effects are likely induced by oxidative stress.
More Related Videos
Related Concept Videos
Formation of Lipopolysaccharides
Inhibitors of Viral Protein Synthesis
Inflammation

